603456.SH
九洲药业
SSE · Healthcare · Drug Manufacturers - Specialty & Generic · CN
CNY 15.71
−5.36%Margins
Gross margin
36.6%
EBITDA margin
25.7%
EBIT margin
16.0%
Net margin
12.5%
FCF margin
19.9%
7.3%
Return on equity
6.2%
Return on assets
9.3%
Return on invested capital
0.49x
Asset turnover
CNY 1.7B
Cash from operations
—
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Mar 1, 2026